Latest Breaking News On - Highly selective - Page 6 : comparemela.com

Tenaya Therapeutics Presents Encouraging New Clinical and Preclinical Data from HDAC6 Inhibitor Program TN-301 for the Potential Treatment of Heart Failure with Preserved Ejection Fraction at the 2023 HFSA Annual Scientific Meeting

Tenaya Therapeutics Presents Encouraging New Clinical and Preclinical Data from HDAC6 Inhibitor Program TN-301 for the Potential Treatment of Heart Failure with Preserved Ejection Fraction at the 2023 HFSA Annual Scientific Meeting
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesJulie seidelWendy ryanWhit tingleySecurities exchangeAdministration of inhibitorsGlobenewswire incCorporate communicationsExchange commissionHeart failure society of americaTenaya therapeutics incOnce daily dosingTarget engagementEmpagliflozin shows additive benefitsHighlights differentiated mechanismFailure society

Tenaya Therapeutics to Present Data for TN-301 and TN-201 at Upcoming Medical Conferences

Tenaya Therapeutics to Present Data for TN-301 and TN-201 at Upcoming Medical Conferences
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMilind desaiWendy ryanJulie seidelGretchen argastLaura robertsonFarshad farshidfarHeart failure society of americaAdministration of inhibitorsStern investor relations incHypertrophic cardiomyopathy medical societyHypertrophic cardiomyopathy medical society scientific sessionsTenaya therapeutics incCorporate communicationsClinical developmentPresent data

Tenaya Therapeutics to Present Data for TN-301 and TN-201 at Upcoming Medical Conferences

Tenaya Therapeutics to Present Data for TN-301 and TN-201 at Upcoming Medical Conferences
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesMilind desaiWendy ryanJulie seidelLaura robertsonGretchen argastFarshad farshidfarHypertrophic cardiomyopathy medical societyTenaya therapeutics incStern investor relations incClinical developmentCorporate communicationsAdministration of inhibitorsHeart failure society of americaHypertrophic cardiomyopathy medical society scientific sessionsHuman phase

EQS-News: Immunic, Inc : Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive Disease Week 2023, Including Its Molecular Mode of Action

Issuer: Immunic, Inc. / Key word(s): Study/Conference Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive Disease Week 2023, Including Its Molecular Mode of Action 06.05.2023

United statesPaula schwartzHella kohlhofJessica breuFranziska buriDaniel vittEdna kaplanExchange commissionDistribution servicesImmunic incRx communications groupPresents clinicalPreclinical dataDigestive disease weekIncluding its molecular modeOrally available

Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive Disease Week 2023, Including Its Molecular Mode of Action

/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for.

United statesDaniel vittEdna kaplanHella kohlhofFranziska buriPaula schwartzJessica breuPrnewswire immunic incRx communications groupExchange commissionImmunic incOrally availableSystemically actingHighly selectivePotent small molecule modulatorTargets regeneration